Profound Medical (PROF) Change in Accured Expenses (2024 - 2026)
Profound Medical's (PROF) quarterly Change in Accured Expenses came in at $311000.0 in Q1 2026, up 3.67% year-on-year from $300000.0 in Q1 2025, and up 677.5% quarter-over-quarter from $40000.0 in Q4 2025.
Profound Medical (PROF) Change in Accured Expenses (2024 - 2026) Analysis & Trends
Profound Medical's Change in Accured Expenses history runs 3 years deep, the most recent figure standing at $311000.0 for Q1 2026.
- On a quarterly basis, Change in Accured Expenses rose 3.67% year-over-year to $311000.0 in Q1 2026; TTM through Mar 2026 was $389000.0, a 76.91% decrease from a year earlier, with the FY2025 full-year figure at $378000.0, down 53.62% from the prior year.
- Change in Accured Expenses advanced to $311000.0 in Q1 2026 per PROF's latest filing, from $40000.0 in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $676000.0 in Q3 2024 and bottomed at -$570000.0 in Q1 2024.
- The 3-year median for Change in Accured Expenses is $245000.0 (2025), against an average of $167111.1.
- Biggest YoY gain for Change in Accured Expenses was 288.89% in 2025; the steepest drop was 130.62% in 2025.
- Year by year, Change in Accured Expenses stood at $646000.0 in 2024, then sank by 93.81% to $40000.0 in 2025, then soared by 677.5% to $311000.0 in 2026.
- Per Business Quant, the three latest PROF Change in Accured Expenses figures stand at $311000.0 (Q1 2026), $40000.0 (Q4 2025), and -$207000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -347.10 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 145.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 21.07 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -250.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Profound Medical | 248.64 Mn | 198.34 Mn | 3.83 Mn | 311,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 311,000.00 |
| Mar 31, 2026 | 311,000.00 |
| Dec 31, 2025 | 40,000.00 |
| Dec 31, 2025 | 40,000.00 |
| Sep 30, 2025 | -207,000.00 |
| Sep 30, 2025 | -207,000.00 |
| Jun 30, 2025 | 245,000.00 |
| Jun 30, 2025 | 245,000.00 |
| Mar 31, 2025 | 300,000.00 |
| Mar 31, 2025 | 300,000.00 |
| Dec 31, 2024 | 646,000.00 |
| Dec 31, 2024 | 646,000.00 |
| Sep 30, 2024 | 676,000.00 |
| Sep 30, 2024 | 676,000.00 |
| Jun 30, 2024 | 63,000.00 |
| Jun 30, 2024 | 63,000.00 |
| Mar 31, 2024 | -570,000.00 |
| Mar 31, 2024 | -570,000.00 |